Igm Biosciences Inc (IGMS)

Dec 18, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) CEO Mary Beth Harler Sells 1,708 Shares - MarketBeat

Dec 18, 2024

Dec 18, 2024

Igm biosciences principal accounting officer sells shares for $4,031 - Investing.com

Dec 18, 2024

Dec 18, 2024

Igm biosciences CEO sells $12,775 in stock - Investing.com

Dec 18, 2024

Dec 18, 2024

IGM Biosciences chief business officer sells shares worth $7,951 By Investing.com - Investing.com Canada

Dec 18, 2024

Dec 18, 2024

IGM Biosciences (NASDAQ:IGMS shareholders incur further losses as stock declines 21% this week, taking five-year losses to 84% - Simply Wall St

Dec 18, 2024

Dec 18, 2024

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Target Price at $17.75 - Defense World

Dec 18, 2024

Dec 15, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $17.75 Average Target Price from Analysts - MarketBeat

Dec 15, 2024

Dec 14, 2024

IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism - Investing.com Australia

Dec 14, 2024

Dec 14, 2024

IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 08, 2024

BMO Capital Markets Begins Coverage on IGM Biosciences (NASDAQ:IGMS) - Defense World

Dec 08, 2024

Dec 08, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Gap Up – Here’s What Happened - Defense World

Dec 08, 2024

Dec 07, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Gap UpStill a Buy? - MarketBeat

Dec 07, 2024

Dec 07, 2024

BMO Capital Initiates Coverage of IGM Biosciences (IGMS) with Outperform Recommendation - MSN

Dec 07, 2024

Dec 06, 2024

IGM Biosciences (NASDAQ:IGMS) Coverage Initiated by Analysts at BMO Capital Markets - MarketBeat

Dec 06, 2024

Dec 05, 2024

BMO sets $21 target for IGM Biosciences with Outperform rating By Investing.com - Investing.com UK

Dec 05, 2024

Dec 04, 2024

IGM Biosciences: Dizzying Number Of Pivots (NASDAQ:IGMS) - Seeking Alpha

Dec 04, 2024

Dec 02, 2024

Quest Partners LLC Decreases Stock Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Dec 02, 2024

Nov 30, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 4.1%Should You Sell? - MarketBeat

Nov 30, 2024

Nov 23, 2024

How to Take Advantage of moves in (IGMS) - Stock Traders Daily

Nov 23, 2024

Nov 23, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Gap DownHere's What Happened - MarketBeat

Nov 23, 2024

Nov 20, 2024

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Price Target at $16.13 - MarketBeat

Nov 20, 2024

Nov 20, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Nov 20, 2024

Nov 15, 2024

Will Imvotamab Data Propel IGM Biosciences To New Heights In 2025? - RTTNews

Nov 15, 2024

Nov 13, 2024

How To Trade (IGMS) - Stock Traders Daily

Nov 13, 2024

Nov 13, 2024

FMR LLC Increases Stake in IGM Biosciences Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip - Simply Wall St

Nov 12, 2024

Nov 11, 2024

Biotech firm backs off its focus on oncology research - The Business Journals

Nov 11, 2024

Nov 11, 2024

IGM Biosciences (NASDAQ:IGMS) Given New $27.00 Price Target at Stifel Nicolaus - MarketBeat

Nov 11, 2024

Nov 11, 2024

Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development - MSN

Nov 11, 2024

Nov 10, 2024

IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 7.8%Here's Why - MarketBeat

Nov 09, 2024

Nov 08, 2024

IGM Biosciences Inc (IGMS) Quarterly 10-Q Report - Quartz

Nov 08, 2024

Nov 08, 2024

IGM Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024

Nov 08, 2024

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

IGM Biosciences earnings missed by $0.21, revenue topped estimates - Investing.com UK

Nov 08, 2024

Nov 08, 2024

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 08, 2024

Nov 08, 2024

IGM Biosciences Reports $61.4M Loss, Extends Cash Runway to 2027 Despite Clinical Progress | IGMS Stock News - StockTitan

Nov 08, 2024

Nov 07, 2024

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 07, 2024

Nov 04, 2024

IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewswire

Nov 04, 2024

Nov 02, 2024

(IGMS) Investment Report - Stock Traders Daily

Nov 02, 2024

Nov 01, 2024

IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7%Should You Sell? - MarketBeat

Nov 01, 2024

Oct 29, 2024

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $15.00 - Defense World

Oct 29, 2024

Oct 28, 2024

IGM Biosciences (NASDAQ:IGMS) Trading 7.7% HigherHere's Why - MarketBeat

Oct 28, 2024

Oct 26, 2024

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Oct 26, 2024

Oct 25, 2024

IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook - Investing.com India

Oct 25, 2024